Correction: Combined poly-ADP ribose polymerase and ataxia-telangiectasia mutated/Rad3-related inhibition targets ataxia-telangiectasia mutated-deficient lung cancer cells

Nicholas R Jette; Suraj Radhamani; Greydon Arthur; Ruiqiong Ye; Siddhartha Goutam; Anthony Bolyos; Lars F Petersen; Pinaki Bose; D Gwyn Bebb; Susan P Lees-Miller

doi:10.1038/s41416-020-0841-7

Correction: Combined poly-ADP ribose polymerase and ataxia-telangiectasia mutated/Rad3-related inhibition targets ataxia-telangiectasia mutated-deficient lung cancer cells

Br J Cancer. 2020 Jun;122(12):1872. doi: 10.1038/s41416-020-0841-7.

Authors

Affiliations

¹ Departments of Biochemistry and Molecular Biology, Robson DNA Science Centre and Charbonneau Cancer Institute, Cumming School of Medicine, University of Calgary, 3330 Hospital Drive NW, Calgary, Alberta, T2N 1N4, Canada.
² Department Oncology, Robson DNA Science Centre and Charbonneau Cancer Institute, Cumming School of Medicine, University of Calgary, 3330 Hospital Drive NW, Calgary, Alberta, T2N 1N4, Canada.
³ Departments of Biochemistry and Molecular Biology, Robson DNA Science Centre and Charbonneau Cancer Institute, Cumming School of Medicine, University of Calgary, 3330 Hospital Drive NW, Calgary, Alberta, T2N 1N4, Canada. leesmill@ucalgary.ca.
⁴ Department Oncology, Robson DNA Science Centre and Charbonneau Cancer Institute, Cumming School of Medicine, University of Calgary, 3330 Hospital Drive NW, Calgary, Alberta, T2N 1N4, Canada. leesmill@ucalgary.ca.

^# Contributed equally.

Abstract

This Article was originally published under Nature Research's License to Publish, but has now been made available under a CC BY 4.0 license. This has now been corrected in both the PDF and HTML versions of the Article.

Publication types

Published Erratum